<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03061305</url>
  </required_header>
  <id_info>
    <org_study_id>STR-001-001</org_study_id>
    <nct_id>NCT03061305</nct_id>
  </id_info>
  <brief_title>Profiling Biospecimens From Cancer Patients to Screen for Molecular Alterations Related to Treatment Selection</brief_title>
  <official_title>Profiling Biospecimens From Cancer Patients to Screen for Molecular Alterations Related to Treatment Selection</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Strata Oncology</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Strata Oncology</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Many patients are treated for advanced cancer without knowledge of underlying molecular
      features that might indicate FDA approved therapies or potential eligibility for
      biomarker-selected clinical trials. Strata Oncology is initiating the Strata Trial
      (STR-001-001) with the primary goal of understanding the proportion of subjects available for
      clinical trials and approved targeted therapies in advanced cancer while assessing the
      feasibility of using a large-scale NGS screening program to match subjects for eligibility
      assessments in clinical trials and/or for approved targeted therapies. The Strata Trial does
      not require additional procedures but rather uses surplus, or leftover tumor specimens for
      molecular profiling.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The Strata Trial is a precision oncology collaboration structured as an observational master
      screening protocol with the aim to match patients to genomically-guided therapeutic protocols
      and/or approved therapies. Subjects enrolled on the Strata trial will submit surplus,
      clinical formalin fixed paraffin-embedded (FFPE) tumor specimens for molecular profiling and
      a test report will be provided back to the investigator. For those subjects identified as
      having molecular variants associated with an affiliated therapeutic protocol and/or approved
      targeted therapy, the Strata report will provide additional relevant information.

      All molecular profiling will be performed in the Strata Oncology CLIA-certified laboratory
      (Ann Arbor, MI). The molecular profiling assays will include targeted next generation
      sequencing (NGS) of DNA and RNA covering a range of actionable genomic variants, such as gene
      mutations (e.g. those in EGFR and BRAF), gene amplifications (e.g. ERBB2) and gene fusions
      (e.g. ALK).

      Subjects who have been identified with genetic alterations relevant to a trial or targeted
      therapy will be followed for treatment changes for three years from the time of signed
      informed consent.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">November 2016</start_date>
  <primary_completion_date type="Anticipated">April 2020</primary_completion_date>
  <study_type>Observational [Patient Registry]</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <target_duration>3 Years</target_duration>
  <primary_outcome>
    <measure>Genetic Alteration Frequency</measure>
    <time_frame>3 years</time_frame>
    <description>To evaluate the proportion of subjects across solid tumors and lymphomas having genetic alterations targeted by approved or investigational therapies.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Assessment of Treatment Selection</measure>
    <time_frame>3 years</time_frame>
    <description>To evaluate the proportion of advanced cancer subjects whose targeted genetic sequencing affected treatment selection and/or clinical trial enrollment.</description>
  </secondary_outcome>
  <enrollment type="Anticipated">100000</enrollment>
  <condition>Cancer</condition>
  <condition>Adult Solid Tumor</condition>
  <condition>Lymphoma</condition>
  <biospec_retention>Samples With DNA</biospec_retention>
  <biospec_descr>
    <textblock>
      leftover tumor tissue, DNA, RNA
    </textblock>
  </biospec_descr>
  <eligibility>
    <study_pop>
      <textblock>
        Subjects with advanced (metastatic or unresectable) histologically-documented solid tumors
        and lymphomas who have surplus FFPE tumor tissue (e.g. biopsy, fine needle aspiration,
        fluid cytology, surgical resection) available will be eligible for the Strata trial.
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Subjects must be â‰¥ 18 years of age.

          -  Subjects must have histologically documented solid tumors or lymphoma.

          -  Specific criteria for individual tumor types are as follows:

               1. Subjects with glioblastoma.

               2. Subjects with pancreatic cancer are eligible at any stage of disease.

               3. Subjects with rare tumors (i.e. cancer started in an unusual place in the body,
                  it is unusual type and requires special treatment) are eligible at stages II-IV

               4. Subjects with other tumor types must have recurrent, relapsed, refractory,
                  metastatic or advanced stages III or IV cancer.

          -  Subjects must have an adequate formalin-fixed paraffin-embedded tumor specimen for
             genomic sequencing.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Kat Kwiatkowski, MPH</last_name>
    <role>Study Director</role>
    <affiliation>Strata Oncology</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Kat Kwiatkowski, MPH</last_name>
    <phone>734-527-0993</phone>
    <email>kat.kwiatkowski@strataoncology.com</email>
  </overall_contact>
  <location>
    <facility>
      <name>University of Alabama, Birmingham</name>
      <address>
        <city>Birmingham</city>
        <state>Alabama</state>
        <zip>35294</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Strata Oncology</last_name>
      <phone>734-527-1000</phone>
    </contact>
  </location>
  <location>
    <facility>
      <name>Kaiser Permanente - Northern California</name>
      <address>
        <city>Vallejo</city>
        <state>California</state>
        <zip>94589</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Strata Oncology</last_name>
      <phone>734-527-1000</phone>
    </contact>
  </location>
  <location>
    <facility>
      <name>Christiana Care Health System</name>
      <address>
        <city>Newark</city>
        <state>Delaware</state>
        <zip>19713</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Strata Oncology</last_name>
      <phone>734-527-1000</phone>
    </contact>
  </location>
  <location>
    <facility>
      <name>Ochsner Clinic Foundation</name>
      <address>
        <city>New Orleans</city>
        <state>Louisiana</state>
        <zip>70121</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Strata Oncology</last_name>
      <phone>734-527-1000</phone>
    </contact>
  </location>
  <location>
    <facility>
      <name>Minnesota Oncology - Burnsville</name>
      <address>
        <city>Burnsville</city>
        <state>Minnesota</state>
        <zip>55337</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Strata Oncology</last_name>
      <phone>734-527-1000</phone>
    </contact>
  </location>
  <location>
    <facility>
      <name>Minnesota Oncology - Coon Rapids</name>
      <address>
        <city>Coon Rapids</city>
        <state>Minnesota</state>
        <zip>55433</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Strata Oncology</last_name>
      <phone>734-527-1000</phone>
    </contact>
  </location>
  <location>
    <facility>
      <name>Fairview Southdale Hospital</name>
      <address>
        <city>Edina</city>
        <state>Minnesota</state>
        <zip>55435</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Strata Oncology</last_name>
      <phone>734-527-1000</phone>
    </contact>
  </location>
  <location>
    <facility>
      <name>Minnesota Oncology - Maplewood Cancer Center</name>
      <address>
        <city>Maplewood</city>
        <state>Minnesota</state>
        <zip>55109</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Strata Oncology</last_name>
      <phone>734-527-1000</phone>
    </contact>
  </location>
  <location>
    <facility>
      <name>St. John's Hospital</name>
      <address>
        <city>Maplewood</city>
        <state>Minnesota</state>
        <zip>55109</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Strata Oncology</last_name>
      <phone>734-527-1000</phone>
    </contact>
  </location>
  <location>
    <facility>
      <name>Metro-Minnesota Community Oncology Research Consortium</name>
      <address>
        <city>Minneapolis</city>
        <state>Minnesota</state>
        <zip>55101</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Strata Oncology</last_name>
      <phone>734-527-1000</phone>
    </contact>
  </location>
  <location>
    <facility>
      <name>Regions Hospital</name>
      <address>
        <city>Minneapolis</city>
        <state>Minnesota</state>
        <zip>55101</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Strata Oncology</last_name>
      <phone>734-527-1000</phone>
    </contact>
  </location>
  <location>
    <facility>
      <name>Minnesota Oncology - Minneapolis</name>
      <address>
        <city>Minneapolis</city>
        <state>Minnesota</state>
        <zip>55404</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Strata Oncology</last_name>
      <phone>734-527-1000</phone>
    </contact>
  </location>
  <location>
    <facility>
      <name>North Memorial Health Care</name>
      <address>
        <city>Robbinsdale</city>
        <state>Minnesota</state>
        <zip>55422</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Strata Oncology</last_name>
      <phone>734-527-1000</phone>
    </contact>
  </location>
  <location>
    <facility>
      <name>Park Nicollet Health Services</name>
      <address>
        <city>Saint Louis Park</city>
        <state>Minnesota</state>
        <zip>55416</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Strata Oncology</last_name>
      <phone>734-527-1000</phone>
    </contact>
  </location>
  <location>
    <facility>
      <name>Minnesota Oncology - Edina</name>
      <address>
        <city>Saint Louis Park</city>
        <state>Minnesota</state>
        <zip>55435</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Strata Oncology</last_name>
      <phone>734-527-1000</phone>
    </contact>
  </location>
  <location>
    <facility>
      <name>Minnesota Oncology - Woodbury Clinic</name>
      <address>
        <city>Woodbury</city>
        <state>Minnesota</state>
        <zip>55125</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Strata Oncology</last_name>
      <phone>734-527-1000</phone>
    </contact>
  </location>
  <location>
    <facility>
      <name>North Mississippi Medical Center</name>
      <address>
        <city>Tupelo</city>
        <state>Mississippi</state>
        <zip>38801</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Strata Oncology</last_name>
      <phone>734-527-1000</phone>
    </contact>
  </location>
  <location>
    <facility>
      <name>University of North Carolina, Chapel Hill</name>
      <address>
        <city>Chapel Hill</city>
        <state>North Carolina</state>
        <zip>27514</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Strata Oncology</last_name>
      <phone>734-527-1000</phone>
    </contact>
  </location>
  <location>
    <facility>
      <name>Hayworth Cancer Center</name>
      <address>
        <city>High Point</city>
        <state>North Carolina</state>
        <zip>27262</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Strata Oncology</last_name>
      <phone>734-527-1000</phone>
    </contact>
  </location>
  <location>
    <facility>
      <name>UNC REX Healthcare</name>
      <address>
        <city>Raleigh</city>
        <state>North Carolina</state>
        <zip>27607</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Strata Oncology</last_name>
      <phone>734-527-1000</phone>
    </contact>
  </location>
  <location>
    <facility>
      <name>Kettering Health Network</name>
      <address>
        <city>Kettering</city>
        <state>Ohio</state>
        <zip>45429</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Strata Oncology</last_name>
      <phone>734-527-1000</phone>
    </contact>
  </location>
  <location>
    <facility>
      <name>UTHealth - Memorial Hemann Cancer Institute</name>
      <address>
        <city>Houston</city>
        <state>Texas</state>
        <zip>77030</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Strata Oncology</last_name>
      <phone>734-527-1000</phone>
    </contact>
  </location>
  <location>
    <facility>
      <name>Gundersen Health System</name>
      <address>
        <city>La Crosse</city>
        <state>Wisconsin</state>
        <zip>54601</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Strata Oncology</last_name>
      <phone>734-527-1000</phone>
    </contact>
  </location>
  <location>
    <facility>
      <name>University of Wisconsin</name>
      <address>
        <city>Madison</city>
        <state>Wisconsin</state>
        <zip>53792</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Strata Oncology</last_name>
      <phone>734-527-1000</phone>
    </contact>
  </location>
  <location>
    <facility>
      <name>Aurora Research Institute</name>
      <address>
        <city>Milwaukee</city>
        <state>Wisconsin</state>
        <zip>53226</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Strata Oncology</last_name>
      <phone>734-527-1000</phone>
    </contact>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>May 2018</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>February 15, 2017</study_first_submitted>
  <study_first_submitted_qc>February 17, 2017</study_first_submitted_qc>
  <study_first_posted type="Actual">February 23, 2017</study_first_posted>
  <last_update_submitted>May 24, 2018</last_update_submitted>
  <last_update_submitted_qc>May 24, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">May 25, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

